Trial Profile
Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 31 Aug 2017 Status changed from recruiting to completed.
- 22 Jun 2017 Planned End Date changed from 31 May 2017 to 31 Jul 2017.
- 22 Jun 2017 Planned primary completion date changed from 30 May 2017 to 30 Jul 2017.